Can Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Can Fite Biopharma
CANF Stock  USD 4.44  0.13  3.02%   
Can Fite's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Can Fite's valuation are provided below:
Gross Profit
560 K
Market Capitalization
15.2 M
Enterprise Value Revenue
14.0998
Revenue
560 K
Quarterly Revenue Growth
(0.36)
There are over one hundred nineteen available fundamental signals for Can Fite Biopharma, which can be analyzed over time and compared to other ratios. Active traders should verify all of Can Fite Biopharma prevailing fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. The Can Fite's current Enterprise Value is estimated to increase to about 72.8 B, while Market Cap is projected to decrease to roughly 37.2 B.

Can Fite Total Revenue

1.09 Million

Check Can Fite financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Can Fite's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6 K, Interest Expense of 12 K or Total Revenue of 1.1 M, as well as many indicators such as Price To Sales Ratio of 55.2 K, Dividend Yield of 0.0 or PTB Ratio of 8.9 K. Can financial statements analysis is a perfect complement when working with Can Fite Valuation or Volatility modules.
  
Build AI portfolio with Can Stock
Check out the analysis of Can Fite Correlation against competitors.

Can Fite Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding396.2 K417.1 K2 M
Very volatile
Total Assets10.5 M10.5 M9.4 M
Slightly volatile
Other Current Liabilities742.8 K830.7 K907 K
Pretty Stable
Total Current Liabilities2.4 M2.4 M2.1 M
Slightly volatile
Other Liabilities2 M2.6 M1.8 M
Slightly volatile
Property Plant And Equipment Net91.8 K158.7 K87.8 K
Slightly volatile
Accounts Payable752 K556.2 K880.9 K
Very volatile
Cash4.6 M4.3 M5.4 M
Pretty Stable
Non Current Assets Total238.5 K158.7 K206.2 K
Pretty Stable
Other Assets1.1 M1 M449.4 K
Slightly volatile
Cash And Short Term Investments8.5 M9.1 M7.6 M
Slightly volatile
Net Receivables84.1 K88.5 K523.7 K
Very volatile
Common Stock Total Equity39.9 M38 M15.6 M
Slightly volatile
Liabilities And Stockholders Equity10.5 M10.5 M9.4 M
Slightly volatile
Non Current Liabilities Total2.3 M1.9 M2 M
Slightly volatile
Other Current Assets1.9 M1.2 M1.7 M
Very volatile
Other Stockholder Equity117.2 M196.3 M109.7 M
Slightly volatile
Total Liabilities4.7 M4.2 M4.1 M
Slightly volatile
Property Plant And Equipment Gross116.6 K218.5 K111.3 K
Slightly volatile
Total Current Assets10.2 M10.3 M9.2 M
Slightly volatile
Accumulated Other Comprehensive Income963.6 K1 M3.1 M
Slightly volatile
Common Stock73.2 M69.8 M25.9 M
Slightly volatile
Property Plant Equipment84.8 K144.9 K87 K
Slightly volatile
Net Tangible Assets7.2 M4 M8.8 M
Slightly volatile
Current Deferred Revenue579.9 K465.8 K436.2 K
Slightly volatile
Capital Surpluse72 M86.1 M92.1 M
Slightly volatile
Deferred Long Term Liabilities1.1 M1.1 M980.5 K
Slightly volatile
Non Current Liabilities Other1.9 M1.8 M2.2 M
Slightly volatile
Net Invested Capital6 M6.3 M4.5 M
Slightly volatile
Net Working Capital8.3 M8 M6.6 M
Slightly volatile
Short Term Investments4.4 M3.5 M2.2 M
Slightly volatile
Short and Long Term Debt Total86.5 K119.6 K79.6 K
Slightly volatile
Long Term Debt Total31.2 K35.1 K38.3 K
Slightly volatile
Capital Lease Obligations86.5 K119.6 K79.6 K
Slightly volatile

Can Fite Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization6 K6.3 K20.3 K
Slightly volatile
Interest Expense12 K12.6 K131.7 K
Pretty Stable
Other Operating Expenses10 M10.1 M9.2 M
Slightly volatile
Research Development6.7 M6.6 M6.2 M
Slightly volatile
Total Operating Expenses10 M10.1 M9.2 M
Slightly volatile
Selling General Administrative3.4 M3.5 M3.1 M
Slightly volatile
Selling And Marketing Expenses23.7 K13.5 K25 K
Slightly volatile
Interest Income282.1 K261.9 K873.4 K
Slightly volatile
Reconciled Depreciation6 K6.3 K17 K
Slightly volatile

Can Fite Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation353.7 K416.3 K329 K
Pretty Stable
Begin Period Cash Flow4.6 M3.9 M5.5 M
Pretty Stable
Depreciation6 K6.3 K20.3 K
Slightly volatile
Capital Expenditures4.3 K4.5 K14 K
Slightly volatile
End Period Cash Flow4.5 M4.3 M5.5 M
Pretty Stable
Sale Purchase Of Stock16.1 M9.2 M20.9 M
Slightly volatile
Issuance Of Capital Stock8.6 M6 M7.3 M
Slightly volatile
Dividends Paid1.8 M3 M1.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio55.2 K58.1 K233.4 K
Slightly volatile
Days Sales Outstanding23.1424.3672.5243
Slightly volatile
Average Payables919.2 K963.6 K897.2 K
Slightly volatile
Stock Based Compensation To Revenue0.520.620.5183
Very volatile
Capex To Depreciation0.70.640.8537
Very volatile
EV To Sales55.2 K58.1 K233.2 K
Slightly volatile
Sales General And Administrative To Revenue6.475.28.9684
Slightly volatile
Research And Ddevelopement To Revenue12.559.8213.5018
Slightly volatile
Capex To Revenue0.00810.00850.0795
Slightly volatile
Cash Per Share0.0040.00420.1919
Slightly volatile
Income Quality0.80.870.978
Very volatile
Net Debt To EBITDA0.770.670.6953
Pretty Stable
Current Ratio3.673.944.4407
Pretty Stable
Receivables Turnover10.9415.5110.3422
Slightly volatile
Debt To Equity0.01650.0220.0238
Slightly volatile
Capex Per Share0.00.07.0E-4
Slightly volatile
Average Receivables11.9 K12.6 K21.1 K
Slightly volatile
Revenue Per Share3.0E-44.0E-40.0191
Slightly volatile
Interest Debt Per Share1.0E-41.0E-40.0107
Slightly volatile
Debt To Assets0.00590.01030.0084
Slightly volatile
Operating Cycle23.1424.3672.5243
Slightly volatile
Ebt Per Ebit1.091.111.0001
Very volatile
Total Debt To Capitalization0.01620.02160.0232
Slightly volatile
Debt Equity Ratio0.01650.0220.0238
Slightly volatile
Quick Ratio3.93.944.6898
Very volatile
Net Income Per E B T0.780.90.9644
Pretty Stable
Cash Ratio3.372.73.0439
Pretty Stable
Cash Conversion Cycle23.1424.3672.5243
Slightly volatile
Days Of Sales Outstanding23.1424.3672.5243
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.151.0171
Slightly volatile
Fixed Asset Turnover5.345.6210.9428
Very volatile
Debt Ratio0.00590.01030.0084
Slightly volatile
Price Sales Ratio55.2 K58.1 K233.4 K
Slightly volatile
Asset Turnover0.130.0850.0974
Pretty Stable

Can Fite Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap37.2 B39.2 B69.1 B
Slightly volatile
Enterprise Value72.8 B39.1 B67.1 B
Slightly volatile

Can Fundamental Market Drivers

Forward Price Earnings2.9665
Cash And Short Term Investments7.9 M

Can Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
6th of June 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Can Fite Financial Statements

Can Fite stakeholders use historical fundamental indicators, such as Can Fite's revenue or net income, to determine how well the company is positioned to perform in the future. Although Can Fite investors may analyze each financial statement separately, they are all interrelated. For example, changes in Can Fite's assets and liabilities are reflected in the revenues and expenses on Can Fite's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Can Fite Biopharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue465.8 K579.9 K
Total Revenue775.1 K1.1 M
Cost Of Revenue6.3 K6 K
Stock Based Compensation To Revenue 0.62  0.52 
Sales General And Administrative To Revenue 5.20  6.47 
Research And Ddevelopement To Revenue 9.82  12.55 
Capex To Revenue 0.01  0.01 
Ebit Per Revenue(10.86)(11.40)

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether Can Fite Biopharma is a strong investment it is important to analyze Can Fite's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Can Fite's future performance. For an informed investment choice regarding Can Stock, refer to the following important reports:
How To Invest In Can
Details
Is Can Stock a good investment?
Details
What is Can Fite's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Can Fite Correlation against competitors.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Can Biotechnology industry sustain growth momentum? Does Can have expansion opportunities? Factors like these will boost the valuation of Can Fite. Projected growth potential of Can fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Can Fite demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Revenue Growth
(0.36)
Return On Assets
(0.82)
Return On Equity
(2.64)
Understanding Can Fite Biopharma requires distinguishing between market price and book value, where the latter reflects Can's accounting equity. The concept of intrinsic value - what Can Fite's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Can Fite's price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Can Fite's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Can Fite should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Can Fite's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY